Cargando…
Sex-Specific Protection of Endothelial Function after Vascular Ischemia/Reperfusion Injury by the Senomorphic Agent Ruxolitinib
Ischemia/reperfusion (I/R)-induced endothelial dysfunction occurs in various cardiovascular disorders. I/R injury is partially driven by the release of cytokines. Known for its use in senotherapy, the JAK inhibitor ruxolitinib is able to block the release of cytokines. We investigated the effect of...
Autores principales: | Saemann, Lars, Naujoks, Paula, Hartrumpf, Lotta, Pohl, Sabine, Simm, Andreas, Szabó, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381013/ https://www.ncbi.nlm.nih.gov/pubmed/37511486 http://dx.doi.org/10.3390/ijms241411727 |
Ejemplares similares
-
Impact of Age on Endothelial Function of Saphenous Vein Grafts in Coronary Artery Bypass Grafting
por: Saemann, Lars, et al.
Publicado: (2023) -
Zingiber officinale Roscoe Rhizome Extract Exerts Senomorphic and Anti-Inflammatory Activities on Human Endothelial Cells
por: Matacchione, Giulia, et al.
Publicado: (2023) -
Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease
por: Miller, Sean J., et al.
Publicado: (2023) -
Cytokine Adsorber Use during DCD Heart Perfusion Counteracts Coronary Microvascular Dysfunction
por: Saemann, Lars, et al.
Publicado: (2022) -
Proteomic and Biological Analysis of the Effects of Metformin Senomorphics on the Mesenchymal Stromal Cells
por: Acar, Mustafa Burak, et al.
Publicado: (2021)